© 2020 MJH Life Sciences and Diagnostic Imaging. All rights reserved.
Oncology CT
Additional PET/CT Tracer to Detect Prostate Cancer
May 14, 2020
Researchers identify 18F-PMSA-1007 as an equally effective radiopharmaceutical for detecting prostate cancer.
Expert Guidance: During COVID-19, Lung Cancer CT Screenings Can Be Postponed
April 27, 2020
21-expert panel outlined 12 recommendations for when you can delay lung cancer screenings and lung nodule evaluations.
PSMA-PET/CT Outpaces Conventional Imaging with High-Risk Prostate Cancer Detection
March 23, 2020
Molecular imaging technique performs better with detection, staging, and determining treatment plans.
NELSON Trail: CT Lung Cancer Screening Benefits Confirmed
January 31, 2020
Decade-long trial shows frequent CT screening reduces high-risk smokers’ likelihood of dying from lung cancer.
What Method Is Best for Detecting Prostate Cancer Metastases?
November 19, 2018
The imaging process provides the most time-efficient sequence with the highest lesion detection rate and conspicuity.
Ga-68 PSMA-11 PET/MRI Superior to Multiparametric MRI in Prostate Cancer Detection
October 22, 2018
Thirty-two men participated in the retrospective study.
Insurance Coverage for Prostate MRIs Overly Restrictive
September 24, 2018
Coverage for prostate MRIs results in challenges for patients and referring physicians seeking to obtain ready access.
Physicians Not Discussing Lung Cancer Screening as per USPSTF Guidelines
August 30, 2018
Despite recommendations, shared decision-making for lung cancer screening in practice may be far from what is intended by guidelines.
More Prostate Imaging Doesn’t Equal Better Care
August 29, 2018
Despite undergoing more imaging outside the VA system, men with low-risk prostate cancer don’t show an improvement in care quality.
Low Dose CT Lung Cancer Screening Program Findings Similar to National Trial
August 14, 2018
Thorough prescreening evaluation is one critical element for a safe and successful lung cancer screening program.